TOKYO -- Japanese drugmaker Takeda Pharmaceutical said Friday it will divest its generic drug joint venture with Israeli partner Teva Pharmaceutical Industries.
Takeda will unload its 49% stake in Teva Takeda Pharma, established in 2016, to Teva, which will then sell the unit to Japanese private equity firm J-Will Partners' subsidiary JKI.
